Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC
Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC

Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC

DSIJ Intelligence Article rating: 4.0

Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc has received marketing authorisation approval from European Commission. The authorisation granted by EC is valid in all the EU member states. 

Strides Pharma Science jumps 4 per cent on receiving USFDA approval
Strides Pharma Science jumps 4 per cent on receiving USFDA approval

Strides Pharma Science jumps 4 per cent on receiving USFDA approval

Abhinav Lahoti Article rating: 4.5

Strides Pharma Science Ltd informed on Friday during the market hours that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP, 10 mg & 20 mg from USFDA.

Buzzing small-cap: Prima Plastics hits new 52-week high
Buzzing small-cap: Prima Plastics hits new 52-week high

Buzzing small-cap: Prima Plastics hits new 52-week high

Apurva Joshi Article rating: 5.0

On Friday, Prima Plastics Limited surged as much as 19.8 per cent and made a fresh 52-week high of Rs 93.40. Later, it got closed 13.6 per cent higher at Rs 88.60 from its previous close of Rs 77.95. From its 52-week low level of Rs 23.80 recorded in March 2020, the stock has recovered approximately 292 per cent. 

RITES trades flat on bagging consultancy order from Haryana Rail Infrastructure Development Corporation
RITES trades flat on bagging consultancy order from Haryana Rail Infrastructure Development Corporation

RITES trades flat on bagging consultancy order from Haryana Rail Infrastructure Development Corporation

DSIJ Intelligence Article rating: 4.0

Railway consultancy firm, RITES Limited announced that it has in a consortium, emerged as an L-1 bidder for a general consultancy order from Haryana Rail Infrastructure Development Corporation Limited for their Haryana Orbital Rail Corridor (HORC).  

Sun Pharma share price slips 2 per cent post settlement order by SEBI
Sun Pharma share price slips 2 per cent post settlement order by SEBI

Sun Pharma share price slips 2 per cent post settlement order by SEBI

DSIJ Intelligence Article rating: 4.4

The shares of the drug manufacturer, Sun Pharmaceutical Industries Ltd had initially touched its 52-week high during the early trade on Friday but soon, slipped by almost 2 per cent after Securities & Exchange Board of India (SEBI) issued an order for settling charges made by a whistleblower.  

Equitas Small Finance Bank gains post announcing launch of countrys first FASTag-powered truck terminal
Equitas Small Finance Bank gains post announcing launch of countrys first FASTag-powered truck terminal

Equitas Small Finance Bank gains post announcing launch of countrys first FASTag-powered truck terminal

DSIJ Intelligence Article rating: 2.3

On Friday, Equitas Small Finance Bank announced that it has joined hands with Maharashtra State Road Development Corporation Limited (MSRDC) and Ocean Highway Facilities & Solutions Pvt Ltd for launching country’s first FASTag-powered truck terminal at Khalapur (Maharashtra), which is on Yashwantrao Chavan Mumbai – Pune Expressway.  

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.2

The market opened in green on February 12, 2021, overall volumes in futures & options currently stand at 7,15,50,040 contracts with a turnover of Rs. 68,81,038.70 crore.

RSS
First26692670267126722674267626772678Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR